Company: DHR
Filing Date: 2025-10-21
Form Type: 10-Q
Source: 0000313616-25-000182
Chunk: 23

Company: DANAHER CORP /DE/
Filing Date: 2025-10-21
Form: 10-Q
Item: Item 1
Chunk 23
---
c)798 797 2.5% senior unsecured notes due 3/30/2030 (€800 million) (the “2030 Euronotes”)(b)936 829 0.75% senior unsecured notes due 9/18/2031 (€1.8 billion) (the “2031 Biopharma Euronotes”)(c)2,041 1,805 0.65% senior unsecured notes due 5/11/2032 (¥53.2 billion) (the “2032 Yen Notes”)(d)355 337 1.35% senior unsecured notes due 9/18/2039 (€1.3 billion) (the “2039 Biopharma Euronotes”)(c)1,450 1,282 3.25% senior unsecured notes due 11/15/2039 ($900 million) (the “2039 Biopharma Notes”)(c)892 892 4.375% senior unsecured notes due 9/15/2045 ($500 million) (the “2045 U.S. Notes”)(b)500 499 1.8% senior unsecured notes due 9/18/2049 (€750 million) (the “2049 Biopharma Euronotes”)(c)870 769 3.4% senior unsecured notes due 11/15/2049 ($900 million) (the “2049 Biopharma Notes”)(c)891 890 2.6% senior unsecured notes due 10/01/2050 ($1.0 billion) (the “2050 U.S. Notes”)(b)982 982 2.8% senior unsecured notes due 12/10/2051 ($1.0 billion) (the “2051 U.S. Notes”)(b)985 985 Other34 13 Total debt16,856 16,005 Less: currently payable(23)(505)Long-term debt$16,833 $15,500 (a) Issued by Danaher Corporation or DH Europe Finance II S.a.r.l. (“Danaher International II”).(b) Issued by Danaher Corporation.(c) Issued by Danaher International II.(d) Issued by DH Japan Finance S.a.r.l. (“Danaher Japan”).(e) Issued